Bone loss after denosumab only partial protection with zoledronate Anjali Nimesh Nimesh4 Aug 2017 9:30 AM ISTDenosumab is a monoclonal antibody which acts as a potent anti-resorptive agent and is now widely used in the treatment of osteoporosis.However, when...
Case Report of Saber Tibia in Paget's Disease of Bone Hina Zahid25 Jun 2018 7:03 PM ISTMaria João Gonçalves and associates have reported a Case Report of Saber Tibia in Paget's Disease of Bone which has appeared in NEJM Case...
Zoledronate significantly benefits elderly women with osteopenia Vinay Singh singh7 Oct 2018 7:25 PM ISTIntravenous administration of bone-strengthening drug every 18 months significantly reduced the risk of fragility fractures in older women with hip...
Bisphosphonates prevent rebound bone decay due to discontinuation of denosumab in Osteoporosis Medha Baranwal Baranwal3 July 2019 7:10 PM ISTRecent research demonstrates that prescribing a bisphosphonate after denosumab has been discontinued could prevent rebound of bone decay symptoms in...
